Hello Anon,
Help to please clarify .. do you have an IDE submission/application in place now or as a non-significant risk device, you only have IRB approval for the study?
------------------------------
Richard Vincins ASQ-CQA, MTOPRA, RAC
Vice President Global Regulatory Affairs
Oriel STAT A MATRIX - ENTERPRISE
------------------------------
Original Message:
Sent: 21-Dec-2023 17:49
From: Anonymous Member
Subject: IDE Adverse Event Reporting
This message was posted by a user wishing to remain anonymous
For a non-significant risk IDE, what is the format used for reporting unanticipated adverse events? Is there a form? Is it free-form text? What specific information should be included? FDA guidance is not much help, as all it says is that it must be reported. Your help/advice is appreciated.